253 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

GTHX

G1 Therapeutics
US$7.100.3%301.1%US$374.1mUS$7.15PS6.4xE51.6%n/a

SRPT

Sarepta Therapeutics
US$140.495.3%23.6%US$13.1bUS$193.59PE283.3xE44.9%n/a

TGTX

TG Therapeutics
US$24.7116.4%134.2%US$3.6bUS$32.43PE37xE43.1%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IVVD

Invivyd
US$0.86-18.6%-48.3%US$109.1mUS$8.65PS45.5xE71.5%n/a

SMCI

Super Micro Computer
US$610.917.7%136.7%US$36.5bUS$880.18PE29.6xE35.0%n/a

ARDX

Ardelyx
US$6.125.5%74.4%US$1.4bUS$11.28PS6.9xE65.5%n/a

FOLD

Amicus Therapeutics
US$11.921.7%-4.4%US$3.5bUS$17.18PS7.8xE61.8%n/a

IREN

Iris Energy
US$8.1310.6%94.5%US$1.5bUS$17.13PS9.2xE125.1%n/a

CLNN

Clene
US$5.202.6%-61.4%US$34.3mUS$55.00PS76.1xE62.6%n/a

APLS

Apellis Pharmaceuticals
US$38.959.0%26.6%US$4.7bUS$70.18PS7.5xE68.1%n/a

MAX

MediaAlpha
US$17.066.2%101.7%US$1.1bUS$24.00PS1.9xE59.4%n/a

BPMC

Blueprint Medicines
US$93.200.4%88.9%US$6.1bUS$127.35PS16.3xE67.4%n/a

ISEE

IVERIC bio
US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

CARG

CarGurus
US$28.16-0.9%56.6%US$2.9bUS$28.88PS3.3xE53.9%n/a

INMB

INmune Bio
US$6.69-4.2%-14.9%US$138.1mUS$19.67PS1555.3xE54.7%n/a

CLRB

Cellectar Biosciences
US$2.083.0%25.7%US$73.5mUS$15.50PB8.2xE65.4%n/a

ALDX

Aldeyra Therapeutics
US$5.3814.2%-28.1%US$320.3mUS$10.00PB3.3xE62.3%n/a

WULF

TeraWulf
US$4.7443.2%153.5%US$1.7bUS$6.57PS15.1xE112.7%n/a

GAUZ

Gauzy
US$11.2820.9%n/aUS$209.8mUS$20.38PS2.3xE92.1%n/a

PTC

PTC
US$176.172.4%24.5%US$21.2bUS$198.66PE71.6xE23.9%n/a

NEON

Neonode
US$3.3630.2%76.8%US$39.6mUS$4.00PS11.7xE105.8%n/a

ASND

Ascendis Pharma
US$138.43-0.9%49.6%US$7.9bUS$192.25PS21.7xE66.5%n/a
Page 1 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.